Recro Pharma CEO Discusses Strong Results In Non-Opioid Pain Treatment Study

By: via Benzinga
Recro Pharma Inc (NASDAQ: REPH) is a micro-cap specialty pharmaceutical company focused on the development of non-opioid products for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.